SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-18-014983
Filing Date
2018-11-06
Accepted
2018-11-06 17:28:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G sc13g1118a2alpha_generexbio.htm SC 13G/A 42126
  Complete submission text file 0001213900-18-014983.txt   43671
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Subject) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-62471 | Film No.: 181164049
SIC: 2834 Pharmaceutical Preparations

Mailing Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999
Business Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999 0114232376363
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A